Biogen Scores a Big Win for ADUHELM™, But the Path Ahead Isn’t Easy!
Biogen, Inc. (NASDAQ: BIIB) ADUHELM™ (aducanumab-avwa), scored an approval from the U.S. Food and Drug Administration (FDA), to become the first drug approved...
Coverage
- All
- Beauty
- Biotechnology
- Cannabis
- Communications
- Education
- Energy
- Entertainment
- Environment
- ETFs
- Finance
- Fitness
- Food and Beverage
- Healthcare
- Hospitality
- Insider Trading
- Investing Ideas
- Macro
- Market Insight
- Miscellaneous
- Power
- Real Estate
- Retail
- Sectors
- Security
- Startups
- Technologies
- Trending
- Uncategorized
5 Stocks to Watch Right Now!
While Industries across the globe are grappling with the pandemic and its impact on their operations, Technology Industry has been focused on minimizing...
An Eagle’s Eye View of AgEagle Aerial Systems!
AgEagle Aerial Systems, Inc. (NYSE: UAVS) is a developer of commercial drones, services and solutions for various industries such as agriculture, critical infrastructure...
Akebia Scores Another Potential Win in Kidney Disease!
Akebia Therapeutics, Inc. (NASDAQ: AKBA), a biopharmaceutical developing cutting-edge therapies for the treatment of patients with kidney diseases, announced the acceptance of the...
4 Reasons Why Ribbon Communications Is Ideal for Your Investment Watchlist!
Ribbon Communications, Inc. (NASDAQ: RBBN) provides comprehensive end-to-end communications and networking solutions such as session border controllers, policy routing and signaling, Intelligent Edge,...
5 Companies For Your Investment Watchlist!
Biotech Companies continue to show resurgence even in these challenging times, with more and more companies persevering with bringing their clinical candidates to...
Cinedigm – A Look at the Bigger Picture!
Cinedigm Corp, (NASDAQ: CIDM), a leading streaming company, has signed a deal with MonteCristo International Entertainment, a wholly owned subsidiary of Broadside Enterprises,...
Scholar Rock Holdings has Rock Solid Growth Prospects!
Scholar Rock Holding (NASDAQ: SRRK), a clinical-stage biopharmaceutical Company, announced the grant of a Fast-Track Designation for apitegromab, a selective inhibitor of myostatin...
Can Lordstown Motors Withstand the latest test of its “Endurance”?
Lordstown Motors Corp. (NASDAQ: RIDE) is taking a drubbing again, after reporting disappointing Q1 earnings, which included higher than expected forecasted expenses and...
